Skip to content

Company · founded 2010

Adeptrix (United States)

Beverly, United States · adeptrix.com

Manage this page

Citations, last 5 years: 87
Works, last 5 years: 7
h-index: 8
Scientists listed: 0
Grants since 2016: 6

Grants received

2025–2026 · research · R43

TauTrace™: An ultrasensitive immunoassay for neurodegenerative protein biomarkers

Vladislav Bergo · Adeptrix (United States) · funded by National Institutes of Health

$499.9k

2024–2025 · research · R43

Immunoassay for Measuring Mutation Activated Kinases Across Multiple Cell Signaling Pathways

Vladislav Bergo · Adeptrix (United States) · funded by National Institutes of Health

$295.2k

2022–2025 · research · R44

HistoneScan™: a multiplex immunoassay for histone epigenetic profiling

Vladislav Bergo · Adeptrix (United States) · funded by National Institutes of Health

$436.9k

2022–2024 · research · R44

HistoneScan™: a multiplex immunoassay for histone epigenetic profiling

Tamil Selvan Anthonymuthu · Adeptrix (United States) · funded by National Institutes of Health

$833k

2022–2024 · research · R44

Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU

Tamil Selvan Anthonymuthu · Adeptrix (United States) · funded by National Institutes of Health

$1M

2022–2026 · research · R44

Multiplexed immunoassay for building patient-specific molecular profiles of CSF amyloid beta and TAU

Vladislav Bergo · Adeptrix (United States) · funded by National Institutes of Health

$1.4M